A novel adenosine 2A receptor antagonist HZ-086 enhances the efficiency of immunotherapy and alleviates the acquired resistance to PD-L1 by restoration of T cell functions

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82273958)
  • Jilin Provincial Science and Technology Department (20230204063YY, 20240404034ZP)
  • Science and Technology Development Fund (0053-2021-AGJ)
  • Guangdong Provincial Key Laboratory of Construction Foundation (2023B1212060022)
  • Guangdong Provincial Natural Science Foundation (2024A1515011452, 2023A1515012521)
  • Guangzhou Municipal Science and Technology Project (2022A0505020024)
  • Traditional Chinese Medicine Bureau of Guangdong Province (20231079)
  • Basic and Applied Basic Research Foundation of Guangdong Province

This publication has 38 references indexed in Scilit: